These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 15767116)

  • 21. Expression of the V264M TFPI mutant in endothelial cell cultures may involve mRNA stability.
    Skretting G; Lien T; Sandset PM; Iversen N
    Thromb Res; 2009 Apr; 123(6):851-5. PubMed ID: 19007969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A kinetic model for simulation of blood coagulation and inhibition in the intrinsic path.
    Qiao YH; Liu JL; Zeng YJ
    J Med Eng Technol; 2005; 29(2):70-4. PubMed ID: 15804855
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of tissue factor pathway inhibitor (TFPI) as topically applied antithrombotic agent.
    Aagaard S; Hjortdal VE; Barker JH
    APMIS Suppl; 2003; (109):102-7. PubMed ID: 12874959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of tissue factor pathway inhibitor and anti-beta-2-glycoprotein-I IgG on thrombin generation.
    Lean SY; Ellery P; Ivey L; Thom J; Oostryck R; Leahy M; Baker R; Adams M
    Haematologica; 2006 Oct; 91(10):1360-6. PubMed ID: 17018385
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Elevated plasma tissue factor levels in neonates with umbilical arterial catheter-associated thrombosis.
    Tay SP; Cheong SK; Boo NY
    Malays J Pathol; 2006 Jun; 28(1):41-8. PubMed ID: 17694958
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tissue factor in trauma and organ dysfunction.
    Gando S
    Semin Thromb Hemost; 2006 Feb; 32(1):48-53. PubMed ID: 16479462
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Heparanase coagulation and cancer progression.
    Nadir Y; Brenner B
    Best Pract Res Clin Haematol; 2009 Mar; 22(1):85-92. PubMed ID: 19285275
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparanase induces tissue factor pathway inhibitor expression and extracellular accumulation in endothelial and tumor cells.
    Nadir Y; Brenner B; Gingis-Velitski S; Levy-Adam F; Ilan N; Zcharia E; Nadir E; Vlodavsky I
    Thromb Haemost; 2008 Jan; 99(1):133-41. PubMed ID: 18217145
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Plasma free tissue factor pathway inhibitor (TFPI) levels and TF-induced thrombin generation ex vivo in men with low testosterone levels.
    Agledahl I; Brodin E; Svartberg J; Hansen JB
    Thromb Haemost; 2009 Mar; 101(3):471-7. PubMed ID: 19277407
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tissue factor: beyond coagulation in the cardiovascular system.
    Breitenstein A; Camici GG; Tanner FC
    Clin Sci (Lond); 2009 Oct; 118(3):159-72. PubMed ID: 19845509
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tissue factor, tissue factor pathway inhibitor and vascular endothelial growth factor-A in carotid atherosclerotic plaques.
    Migdalski A; Kotschy M; Jawien A
    Eur J Vasc Endovasc Surg; 2005 Jul; 30(1):41-7. PubMed ID: 15933981
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of tissue factor pathway inhibitor-2 in cancer biology.
    Sierko E; Wojtukiewicz MZ; Kisiel W
    Semin Thromb Hemost; 2007 Oct; 33(7):653-9. PubMed ID: 18000791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Tissue factor and tissue factor pathway inhibitor during specific bronchial challenge in allergic asthma patients].
    Kemona-Chetnik I; Bodzenta-Lukaszyk A; Kucharewicz I; Rogalewska AM
    Przegl Lek; 2005; 62(2):98-101. PubMed ID: 16095153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Computational modeling of factor Xa inhibition by immobilized tissue factor pathway inhibitor.
    Tummala SR; Hall CL
    Ann Biomed Eng; 2007 Mar; 35(3):408-18. PubMed ID: 17219083
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Elevated TFPI levels in female hyperhomocysteinemic patients.
    Thyzel E; Siegling S; Götting C; Kleesiek K
    Clin Biochem; 2005 Nov; 38(11):1038-40. PubMed ID: 16081056
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue factor and its inhibitor in human non-crescentic glomerulonephritis--immunostaining vs plasma and urinary levels.
    Naumnik B; Borawski J; Chyczewski L; Pawlak K; Mysliwiec M
    Nephrol Dial Transplant; 2006 Dec; 21(12):3450-7. PubMed ID: 16982632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A concentrated parameter model for the human cardiovascular system including heart valve dynamics and atrioventricular interaction.
    Korakianitis T; Shi Y
    Med Eng Phys; 2006 Sep; 28(7):613-28. PubMed ID: 16293439
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [A numerical study of the stability of some autowave solutions in a mathematical model of blood coagulation].
    Kurilenko IA; Lobanov AI; Ukrainets AV
    Biofizika; 2009; 54(1):68-76. PubMed ID: 19334635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evaluation of plasma tissue factor and tissue factor pathway inhibitor levels in childhood hemangiomas.
    Türker M; Irken G; Oren H; Yilmaz S; Yüksel F; Olgun N
    Pediatr Blood Cancer; 2006 Dec; 47(7):914-7. PubMed ID: 16395682
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differential effects of estrogens and progestins on the anticoagulant tissue factor pathway inhibitor in the rat.
    Shirk RA; Zhang Z; Winneker RC
    J Steroid Biochem Mol Biol; 2005 Mar; 94(4):361-8. PubMed ID: 15857755
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.